Lung Cancer Proteomics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Lung Cancer Proteomics

Access the complete profile.

Lung Cancer Proteomics Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	621511 Medical Laboratories
Address	6541 Via Del Oro, Ste B San Jose, CA 95119

Note: Revenues for privately held companies are statistical evaluations.


Lung Cancer Proteomics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Lung Cancer Proteomics's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Lung Cancer Proteomics is classified as operating in the Medical Laboratories industry, NAICS Code 621511.

Lung Cancer Proteomics Annual Revenue and Growth Rate

Lung Cancer Proteomics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Lung Cancer Proteomics's revenues are gauged from an analysis of company filings.

Lung Cancer Proteomics's Income Statement (based on Industry Averages)

Lung Cancer Proteomics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Market Share of Lung Cancer Proteomics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Lung Cancer Proteomics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
PHYSICIANS IMMUNODIAGNOSTIC LABORATORY	Burbank, CA	100
ACCU REFERENCE MEDICAL LAB LIMITED LIABILITY	Linden, NJ	100
CENTOGENE US	Cambridge, MA	88
LATARA ENTERPRISE	Pomona, CA	61
TELIGENT PHARMA	Vineland, NJ	46
COVID CLINIC	Huntington Beach, CA	37
VIKOR SCIENTIFIC	Charleston, SC	33
BIOTHERANOSTICS	San Diego, CA	31
SHERMAN-ABRAMS LABORATORY	Brooklyn, NY	31

Nearby Competitors

These companies are similar in business line and location to Lung Cancer Proteomics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
OXFORD BIOTHERAPEUTICS	San Jose, CA	100
LUNG CANCER PROTEOMICS	San Jose, CA	43
CIPHEROME	San Jose, CA	33
CALIFORNIA INSTITUTE FOR MEDICAL RESEARCH	San Jose, CA	12
CLIMAX LABORATORIES	San Jose, CA	3
JUVENTAS	San Jose, CA	2

Future Competition: Lung Cancer Proteomics's Fastest Growing Competitors

These companies are in the same general field as Lung Cancer Proteomics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)